Dr. William Hixson from the Gulf Coast Cancer Center joined us on Studio10 to discuss some important information about Prostate Cancer.
(All the information below was provided by the folks at the Gulf Coast Cancer Center)
The advent of PSA was associated with dramatic improvements in Prostate Cancer survival. We know that screening for Prostate Cancer catches more cancers in the earlier stages and that those cancer do better with treatment.
The recent studies that failed to demonstrate the effectiveness of PSA based Prostate Cancer screening were significantly flawed and the panels making those recommendations did not include any oncologists or urologists. Both arms of the study underwent PSA screening to some degree. There is no way to detect the difference between two arms of a study that are somewhat identical.
PSA screening is STILL recommended by organizations such as American Urological Association, National Comprehensive Cancer Center Network, and American Cancer Society AFTER a discussion of the risks and benefits of screening. a process referred to as shared decision making. Patients and Doctors using common sense to decide what is best for the individual patient. As it has always been and as it should always be. Unless insurers get on the bandwagon against screening and begin to indiscriminately deny such useful screening tools.
The recomendation regarding screening is against routing PSA screening. What does this mean? Not everyone should be screened. But it does not mean that everyone should be unscreened as has been the interpretation by some within the media. see forbes article november 2013 in response to the annals of internal medicine article conclusions regarding screening “Great News For Guys: No More Invasive Prostate Exams!” which discusses psa based screening.
The treatment for prostate cancer has improved dramatically in both effectiveness and side effects. Advances in Radiation Therapy have made radiation therapy primarily a logistical inconvenience and little more. Side effects are minimal both short term and long term and cure rates are excellent. The use of prostate seed implantation in combination with hormonal therapy and external radiation therapy have brought the outcomes of the higher risk cancer in line with lower and intermediate risk cancers. The Calypso technology, referred to as GPS for the body, is another significant advance in the fight against prostate cancer which is offered exclusively in the State of Alabama at Gulf Coast Cancer Centers. Calypso first localizes the position of the prostate gland prior to treatment and tracks the position of the prostate through the entire treatment process.
*About 233,000 new cases of prostate cancer will be diagnosed
*About 29,480 men will die of prostate cancer
Gulf Coast Cancer Center
29653 Anchor Cross Blvd.
Daphne, AL 36526